Boston Scientific Signs an Agreement with BPEA to Acquire Lumenis’ Surgical Business

 Boston Scientific Signs an Agreement with BPEA to Acquire Lumenis’ Surgical Business

Boston Scientific Signs an Agreement with BPEA to Acquire Lumenis’ Surgical Business

Shots:

  • Boston Scientific to acquire the global surgical business of Lumenis for $1.07B as an up front in cash. The transaction is expected to be completed in H2’21
  • BPEA will retain ownership of the Lumenis global aesthetics and ophthalmology businesses. The acquisition will expand Boston Scientific’s global kidney stone management portfolio and will expand its footprints in the EU and Asia
  • Lumenis’ surgical business includes premier laser systems, fibers and accessories used for urology and otolaryngology procedures

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Medical Device and Diagnostic Industry

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post